Background/Aims: Osteoarthritis (OA) is one of the most common chronic degenerative diseases. Many studies have demonstrated the role of microRNAs (miRNAs) in OA; however, the role of miR-302b in OA remains elusive. The aim of this study was to identify the role of miR-302b in LPS-induced injury in chondrocytes. Methods: Human OA chondrocytes (C28/12 cell line) were transfected with miR-302b inhibitor and miR-302b mimic to investigate the effects of miR-302b expression on chondrocyte apoptosis and inflammation, and to identify the miR-302b target proteins. Results: LPS treatment of chondrocytes significantly reduced cell viability and increased apoptotic rate. LPS treatment also increased the expression of inflammatory cytokines compared to control. miR-302b was up-regulated in LPS-induced chondrocytes. miR-302b was either suppressed or overexpressed in LPS-induced chondrocytes by transient transfection. miR-302b mimic transfection accelerated the effects of LPS on cell viability, apoptosis and inflammation. Of contrast, miR-302b inhibition represented a reverse effect. Dual luciferase activity demonstrated that Smad3 is a direct target for miR-302b and its expression was negatively regulated by miR-302b. In addition, miR-302b inhibition suppressed inflammation in LPS treated chondrocytes by up-regulating Smad3 expression. Moreover, LPS induced down-regulation of Notch and mTOR signaling pathway-related protein expressions, and miR-302b inhibition increased the expressions of Notch and mTOR signaling pathwayrelated proteins. We further found that miR-302b negatively regulated Notch2 levels through direct targeting its 3'UTR. Conclusions: These results suggest that miR-302b suppression may function as a protector in suppressing the inflammation during the development and progression of OA by up-regulating the target Smad3 expression.
Introduction
Osteoarthritis (OA) is one of the commonest chronic degenerative diseases, especially among the old age people, seriously affects the quality of life of the affected patients Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry [1, 2] . OA is characterized by deterioration of functions of chondrocytes, an integral part of articular cartilage, subchondral bone and joint margins [1] . Studies have shown that proteolytic enzymes such as matrix metalloproteinases (MMP), secreted by chondrocytes are involved in degradation of cartilage [2, 3] . The pathogenesis of OA is a multifactorial disorder with genetic, developmental, biochemical and biomechanical factors contributing to the development of disease process [1, 3] . Gene expression alterations including those of microRNAs (miRNAs), in chondrocytes are involved in the synthesis and degradation of cartilage [4] [5] [6] [7] [8] [9] . Research into the regulatory mechanisms underlying the pathogenesis of OA is therefore warranted, and there has been an increased interest in understanding the functional role of miRNAs in OA pathogenesis. miRNAs are small (17-25 nucleotide long) non-coding RNAs regulating the expression of multiple target genes; approximately one-third of the mammalian genes are regulated by these miRNAs [9, 10] . A study by Kobayashi et al. found that chondrocyte proliferation and differentiation was regulated by dicer-dependent pathways [11] . Jones et al. in their study have identified seventeen human miRNAs which showed greater differential expression (about 4-fold) between normal and OA cartilage [12] . A study by Díaz-Prado1 et al. has found seven human miRNAs showed a statistically significant differential expression, of which one was up-regulated in OA chondrocytes (hsa-miR-483-5p) and another six were upregulated in normal chondrocytes [13] . The results of these studies revealed the possibility of involvement of miRNA in OA pathogenesis. Previous studies have reported that miRNAs could act as accelerants or suppressants in OA pathogenesis, dependent on their specific species. For example, hsa-miR-148a overexpression promoted cartilage production, while its inhibition led to cartilage degradation in OA chondrocytes [11] . miR-33a regulated cholesterol synthesis and cholesterol efflux-related genes in OA chondrocytes [12] . miR-149 down-regulation in OA chondrocytes showed an increased expression of pro-inflammatory cytokines (TNFα, IL-1β, and IL-6) [14] . Subsequently, miR-125b regulated the expression of aggrecanase-1 (ADAMTS-4) in human OA chondrocytes [15] . Therefore, miRNAs could exert positive or negative effect on OA chondrocyte metabolism. It is of great benefit to identification of the effect of miRNA on chondrocyte metabolism and the further mechanism, and it may allow us to better understand OA etiology and ultimately contribute to the development of potential approach for OA therapy.
The family of miR-302 consists of four highly-homologous miRNA members, which are transcribed together as a noncoding RNA cluster containing miR-302b, miR-302c, miR302a, miR-302d, and miR-367 in a 5′-to-3′ direction [16, 17] . These post-transcriptionally regulate CCND1 and CDK4, in turn affecting cell cycle progression. Previous studies have demonstrated the role of tumor suppression in human pluripotent stem cells by both the CCNE-CDK2 and CCND-CDK4/6 pathways in G1-S cell cycle transition. However, the relationship between miR-302b and OA regulation has not been elucidated [18] . A single miRNA species can regulate multiple targets with the same ''seed region''. Thus, the present study was to investigate the role of miR-302b in the regulation of LPS-induced injury in chondrocytes and to further explore its potential mechanism.
Materials and Methods

Cell culture and treatment
Human cartilage C28/I2 cells were purchased from the American Type Culture Collection (Manassas, VA) and cultured in complete Roswell Parker Memorial Institute (RPMI)-1640 medium (Gibco-BRL, Gaithersburg, MD, USA) supplemented with 10% fetal bovine serum (FBS; Gibco-BRL) in a humidified incubator containing 5% CO 2 at 37°C. All cells were used between the fifth and tenth passages after thawing. Cells were plated in 12-well plates (5 x 10 5 cells/cm 2 ) for 24 h before stimulation. Cells were treated by LPS in a series of concentration for 5 h.
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CCK-8 assay
Cells were seeded in 96-well plate with 5000 cells/well, cell viability was assessed by a Cell Counting Kit-8 (CCK-8, Dojindo Molecular Technologies, Gaithersburg, MD). Briefly, after LPS stimulation for 5 h, the CCK-8 solution was added to the culture medium, and the cultures were incubated for 1 hour at 37°C in humidified 95% air and 5% CO 2 . The absorbance was measured at 450 nm using a Microplate Reader (BioRad, Hercules, CA). 
Apoptosis assay
ELISA
Culture supernatant was collected from 24-well plates and concentrations of inflammatory cytokines measured by enzyme-linked immunosorbent assay (ELISA) using protocols supplied by the manufacturer (R&D Systems, Abingdon, UK) and normalized to cell protein concentrations.
miRNAs transfection miR-302b mimic, miR-302b inhibitor and si-Smad3 and the corresponding negative controls (NC) were synthesized by GenePharma Co. (Shanghai, China). Cell transfections were conducted using Lipofectamine 3000 reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's protocol.
Quantitative real-time polymerase chain reaction (qRT-PCR)
Total RNA was extracted from cells using Trizol reagent (Life Technologies Corporation, Carlsbad, CA, USA) according to the manufacturer's instructions. The Taqman MicroRNA Reverse Transcription Kit and Taqman Universal Master Mix II with the TaqMan MicroRNA Assay of miR-302b and U6 (Applied Biosystems, Foster City, CA, USA) were used for testing the expression levels of miR-302b in cells. The mRNA expression levels of Notch2, Smad3 and inflammatory cytokines were determined by qRT-PCR using the SYBR Green Master Mix (Takara, Dalian, China). The results were presented as fold changes relative to U6 or GAPDH and were calculated using the 2 -△△CT method.
Dual luciferase activity assay
The 3'UTR target site was generated by PCR and the luciferase reporter constructs with the Smad3 3'UTR carrying a putative miR-302b-binding site into pMiR-report vector (Promega, Madison, WI, USA) were amplified by PCR. Cells were co-transfected with the reporter construct, control vector and miR302b mimic or scramble using Lipofectamine 3000 (Life Technologies, USA). For the analysis of Notch2 and miR-302b, the luciferase reporter constructs with the Notch2 3'UTR carrying a putative miR-302b-binding site into pMiR-report vector (Promega) were amplified by PCR. Cells were co-transfected with the reporter construct, control vector and miR-302b mimic or scramble using Lipofectamine 3000 (Life Technologies). Reporter assays were done using the dual-luciferase assay system (Promega) following to the manufacturer's information. pRL-Tk Renilla luciferase vector was used as an internal control.
Western blot
The protein used for western blotting was extracted using RIA lysis buffer (Beyotime Biotechnology, Shanghai, China) supplemented with protease inhibitors (Roche, Guangzhou, China). The proteins were quantified using the BCA™ Protein Assay Kit (Pierce, Appleton, WI, USA). The western blot system was established using a Bio-Rad Bis-Tris Gel system according to the manufacturer's instructions. GAPDH antibody was purchased from Sigma (St Louis, MO, USA). Other primary antibodies: anti-Bcl-2 (#4223), antiBax (#5023), anti-caspase-3 (#9662), anti-caspase-9 (#9502), anti-Notch1 (#3608), anti-Notch2 (#4530), anti-Notch3 (#5276), anti-mTOR (#2983), anti-p-mTOR (#5536), anti-p70S6K (#2708), and anti-p-p70S6K were purchased from Cell Signaling Technology (Beverly, MA, USA). Primary antibodies were prepared in Cellular Physiology and Biochemistry
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5% blocking buffer at a dilution of 1:1, 000. Primary antibody was incubated with the membrane at 4°C overnight, followed by wash and incubation with secondary antibody marked by horseradish peroxidase for 1 hour at room temperature. After rinsing, the PolyvinylideneDifluoride (PVDF) membrane carried blots and antibodies were transferred into the Bio-Rad ChemiDoc™ XRS system, and then 200 μl Immobilon Western ChemiluminescentHRP Substrate (Millipore, MA, USA) was added to cover the membrane surface. The signals were captured and the intensity of the bands was quantified using Image Lab™ Software (BioRad, Shanghai, China).
Statistical analysis
All experiments were repeated three times. The results of multiple experiments are presented as mean ± SD. Statistical analyses were performed using SPSS 19.0 statistical software (SPSS, Inc., Chicago, IL, USA). The P-values were calculated using one-way analysis of variance (ANOVA). A P-value of <0.05 was considered to be statistically significant.
Results
LPS exposure induced cell apoptosis and inflammation in chondrocytes LPS
usually induces inflammation and causes cell apoptosis. The cell viability of chondrocytes was detected by CCK-8 assay. As shown in Fig.  1A , the relative cell viability was significantly decreased by 50% after treatment with 5 mg/L and 10 mg/L LPS compared to control (P<0.01 and P<0.001). Flow cytometry was utilized to quantify LPSinduced chondrocytes apoptosis. As shown in Fig. 1B , the percentage of apoptotic cells was increased significantly (P<0.05, P<0.01, and P<0.001) following exposure to LPS in a dose dependent manner. The analysis of apoptosis-related protein by western blotting confirmed these results, as the expression of pro-apoptotic factors (Bax, cleavedcaspase-3 and cleaved-caspase-9) were significantly up-regulated and the anti-apoptotic factor (Bcl-2) was down-regulated (Fig. 1C) . After incubation with LPS, expressions of IL-1β, IL-6, IL-8, and TNF-α were detected by qRT-PCR and ELISA (Fig.  1D-1H ). Results showed that the expression levels of inflammatory cytokines were significantly increased compared to the control and LPS-induced secretion of IL-1β, IL-6, IL-8 and TNF-α (all P<0.001). 
miR-302b was up-regulated in LPS treated chondrocytes
The isolated chondrocytes were treated with LPS to induce inflammation in vitro, the expression level of miR302b was then detected by qRT-PCR. As shown in Fig.  2A , the miR-302b level was significantly increased (P<0.05) in LPS treated cells compared to control group of cells. We further transfected miR-302b inhibitor and miR-302b mimic to chondrocytes to alter miR-302b expression. As shown in Fig. 2B , the expression of miR-302b in chondrocytes was significantly enhanced after transfection with miR-302b mimic compared to scramble (P<0.001) while significantly decreased (P<0.01) after transfection with miR-302b inhibitor compared to NC.
Effects of miR-302b expression on cell apoptosis and inflammation in LPS treated chondrocytes
To investigate the role of miR-302b, the chondrocytes were transfected with miR302b mimic and treated with LPS. As shown in Fig. 3A Fig. 3B ). Western blot analysis of apoptosis-related factors also showed similar results (Fig. 3C) . The expression of inflammatory cytokines (IL-1β, IL-6, IL-8 and TNF-α) were significantly increased in the LPS+miR-302b mimic compared to LPS+scramble, similarly opposite results were obtained in LPS+ miR-302b inhibitor group of cells (Fig.3D, P<0.05) . Also, the levels of inflammatory cytokines were significantly increased in LPS+miR-302b mimic compared to scramble and opposite results were observed in the LPS+ miR302b inhibitor group of cells (P<0.05, Fig. 3E-3H ).
Smad3 is a direct target for miR-302b
Smad3, as an intracellular molecule that is linked to the extracellular TGF-β signals, plays an important role in cartilage development and inflammation [19] . Smad3 was hypothesized to be a potential target of miR-302b. Fig. 4A demonstrated that the expression of Smad3 was negatively correlated to the expression of miR-302b (P<0.05 and P<0.01). Western blotting analysis results also suggested decreased expression of Smad3 in miR302b mimic (Fig. 4B) . To verify whether miR-302b was able to directly bind to its seed sequence in the Smad3 3'-UTR in chondrocytes, we designed mutation in this sequence and generated luciferase reporter plasmid constructs, in which wildtype and mutant of Smad3 3'-UTR were connected to the luciferase reporter gene (Fig.  4C) . Luciferase reporter assay revealed that the luciferase activity was significantly reduced in chondrocytes when co-transfected with Smad3-wt and miR-302b mimic compared with the control group (Fig. 4D, P<0 .05). The data indicates that miR-302b is able to directly bind to its seed sequences in the Smad3 3′-UTR in chondrocytes. Therefore, Smad3 was identified as a target of miR-302b in human chondrocytes.
Suppression of miR-302b suppressed inflammation in LPS treated chondrocytes by up-regulating expression of Smad3
Results from Fig. 5A demonstrated that cell viability was significantly increased in the LPS+miR-302b inhibitor compared to LPS+NC and LPS+miR-302b inhibitor+si-Smad3 (P<0.05). Results regarding the percentage of apoptotic cells demonstrated a significant decrease in the percentage of apoptotic cells in LPS+ miR-302b inhibitor group of cells compared to LPS+NC (P<0.05) group of cells, while a significant increase in apoptosis was observed in the LPS+miR-302b inhibitor+si-Smad3 group of cells compared to LPS+miR-302b inhibitor group (P<0.01, Fig.  5B ). Western blotting analysis showed similar results (Fig. 5C ). The expression of inflammatory cytokines was decreased in LPS+ miR-302b inhibitor while increased in LPS+ miR-302b inhibitor +si-Smad3 (Fig. 5D) . Similarly, the levels of IL-1β (Fig. 5E, P<0 .01), IL-6 (Fig. 5F , P<0.05), IL-8 (Fig. 5G, P<0 .05), and TNF-α (Fig. 5H, P<0 .05) showed a significant decrease in the cells treated with LPS and transfected with miR-302b inhibitor as in LPS+ miR-302b inhibitor group of cells and a significant increase in the LPS+ miR-302b inhibitor+si-Smad3. The aforementioned data suggest that suppression of miR-302b suppressed inflammation in LPS-treated chondrocytes by up-regulating Smad3 expression.
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miR-302b modulated expressions of Notch and mTOR pathways-related protein, and Notch2 was a direct target of miR-302b
Furthermore, to explore the significant molecular mechanism of miR-302b on the signal pathway related-protein expression, we therefore, analyzed the protein expression on Notch and mTOR signal pathways. The data showed that the Notch signal pathway-related protein including Notch1, Notch2, and Notch3 were all significantly down-regulated by the LPS treatment (Fig. 6A) . However, when the LPS-induced cells were transfected with miR-302b mimic or inhibitor, the expression of Notch signal pathway-related protein was all significantly decreased by the miR-302b mimic, whereas significantly up-regulated by miR-302b inhibitor respectively (Fig. 6A) . These data revealed that Notch signal pathway was activated by the suppressed miR-302b in LPS treated cells. Similarly, we also observed that the mTOR signal pathway was also activated by the inhibited miR-302b in LPS treated cells (Fig. 6B) . We further investigated whether miR-302b regulated Notch pathway factors through direct targeting its mRNA 3'UTR. As shown in Fig. 6C , we found the predicted miR302b-targeted sequences in the mRNA of Notch2. And the result of dual luciferase activity assay revealed that miR-302b overexpression significantly reduced the luciferase activity of constructs containing 3'-UTR of the wild-type Notch2 (Fig. 6D, P<0 .05), and the mRNA and protein expression of Notch2 was negatively controlled by miR-302b ( Fig. 6E and 6F , P<0.01, P<0.001). All of these data implicated that miR-302b suppression may contribute to the activations of Notch and mTOR signal pathways in LPS-induced cells in OA, and Notch2 was a direct target of miR-302b.
Discussion
OA is a complex, multifactorial inflammatory disease affecting the whole bony joint [20] . More than 25 miRNAs have been demonstrated to be associated with OA and many of them are functionally implicated in the pathogenesis of the disease [3] . Previous studies have reported that miRNAs have been expressed differentially in normal and OA chondrocytes [12, 13] . According to Meng et al., miR-320 was found to target MMP13, and expression of this miRNA was predicted to be a contributory factor in OA pathogenesis [21] . Several miRNAs were included in the pathogenesis of OA, which include miR-140 was expressed in cartilage to regulate cartilage development and homeostasis, and its loss contributes to the development of age-related OA-like changes [22] . It was also reported that miR-21 was upregulated in OA patients, and its overexpression attenuates the process of chondrogenesis [22] . Furthermore, recent studies have revealed that miR-381 expression was elevated in chondrogenic and hypertrophic ATDC5 cells and it may contribute to absorption of the cartilage matrix by repressing type II collagen and inducing MMP-13 [23] . Another report demonstrated that mi-146a was up-regulated after hypoxia exposure and promoted chondrocyte autophagy through Bcl-2 [24] . In contrast to the above results, our data indicated that suppression of miR-302b suppressed LPS-induced injury of the chondrocyte cells. Our study found that knockdown of miR-302b exerts a protective role in human OA chondrocytes, which was in line with a previous study [25] .
There was a significant reduction of cell viability and an increase of apoptosis in chondrocytes after LPS exposure (Fig. 1A and 1B ). What's more, LPS treatment significantly increased the expression of inflammatory cytokines (Fig. 1D-1H ). miR-302b was upregulated in LPS-induced chondrocytes ( Fig. 2A) . miR-302b mimic promoted the LPSinduced chondrocytes reduction of cell viability and increase of apoptotic rate (Fig. 3A  and 3B ). LPS-induced treatment in cells transfected with miR-302b mimic demonstrated increased the expression levels of inflammatory cytokines (Fig. 3D-3H ). Smad3 is a direct target for miR-302b (Fig. 4) . Suppression of miR-302b suppressed inflammation in LPStreated chondrocytes by up-regulating Smad3 expression (Fig. 5) .
miRNAs play an important role in both adaptive and innate immunity. miR-302b is a novel inflammatory regulator acting via TLR-mediated immunity pathway [26] . miR-302b Cellular Physiology and Biochemistry
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was also confirmed to be a feedback negative regulator for LPS-induced inflammation [26] . miR-302b is always overexpressed in tumors and inhibits cell apoptosis to promote cancer progress [17] . It is also observed to reprogram human skin cancer cells into a pluripotent ES cell-like state [16] . The present study investigated the role of miR-302b in human chondrocytic cells. The results showed that transfection of si-miR-302b exhibited antiinflammatory and anti-apoptotic effects in LPS-treated chondrocytes. Recent evidence have revealed that the Notch pathway function as a potential regulator of both catabolic and anabolic molecules in the cartilage extracellular matrix during development [27] . Activation of Notch pathway is crucial for OA development [28, 29] . Notch signaling may contribute to enhanced production of inflammation-related molecules in OA synoviocytes and chondrocytes [30, 31] . Targeting Notch signaling during OA leads to the restitution of the typical chondrocyte phenotype and even to chondrocyte redifferentiation during the pathology [32] . mTOR, a serine/threonine protein kinase, plays a critical role in autophagy. It has been demonstrated that an inactive mTOR pathway can induce autophagy occurrence, while autophagy can be inhibited by activating mTOR [33] . Recent evidence showed that mTOR suppression promotes autophagy of articular chondrocytes and attenuates inflammatory response in osteoarthritis in vivo and vitro [34] . Our results showed that miR-302b overexpression inhibited the activation of Notch and mTOR pathways in LPS-injured chondrocytes. Since miR-302b mimic reduced phosphorylated mTOR and phosphorylated p70S6K but not alter the levels of total mTOR and total p70S6K, indicating that mTOR and p70S6K are not directly targeted by miR-302b. But, we demonstrated that Notch2 was a direct target of miR-302b and its expression was negatively correlated with miR-302b levels. Furthermore, our results showed that miR-302b mimic also reduced the expression of Notch1 and Notch3. It has reported that STAT3 has a close interaction with Notch receptors in various physiological and pathological conditions, including proliferation, differentiation, and apoptosis [35] . Furthermore, STAT3 is a downstream signal of mTOR [36] [37] [38] . Thus, we surmised that miR-302b may indirectly Notch1/3 expression through PI3K/AKT/mTOR pathway and some potential downstream factors. However, more details need to further verify the hypothesis and explore the molecular mechanism of miR-302b in the regulation mTOR pathway and Notch 1/3 expression. The data presented in our study reveals that miR-302b suppression may function as a protector in suppressing the inflammatory reactions during the development and progression of OA by direct upregulating Smad3 expression (Fig. 7) . Hence, there is increasing evidence which suggests that miR-302b convey a novel and efficient means in gene expression regulation. Understanding and gaining knowledge on its expression and dynamic regulation helps in enhancing chondrogenic differentiation. This in turn might affect current treatment protocol of Fig. 7 . The overall mechanism of miR-302b regulation in LPS injured chondrocytes. LPS induced the increase of cell apoptosis and inflammation in chondrocytes, meanwhile, miR-302b level was elevated. miR-302b negatively regulated Smad3 expression through direct targeting its 3'UTR. miR-302b inhibition suppressed apoptosis and inflammation in LPS treated chondrocytes via up-regulating expression of Smad3. Moreover, miR-302b could inhibit Notch and mTOR pathways. Interesting, Notch2 was a direct target of miR-302b, and its expression was negatively correlated with miR-302b levels. Abbreviations: LPS: Lipopolysaccharide; mTOR: Mechanistic target of rapamycin.
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OA as it would aim at preventing tissue destruction and driving repair. Unraveling the role of miR-302b in joint physiology and pathology will shed light upon the diagnosis, prevention, and treatment of OA.
In conclusion, these results suggest that miR-302b suppression may function as a protector in suppressing the inflammation during the development and progression of OA by up-regulating the target Smad3 expression.
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